Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic
- PMID: 20194150
- PMCID: PMC2843108
- DOI: 10.4065/mcp.2009.0426
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic
Abstract
Objective: To define age-adjusted incidence trends in multiple myeloma (MM) in a well-characterized population during a long period, given that some, but not all, studies have reported increasing MM incidence over time and that clinical experience from some centers suggests an increased incidence mainly in younger age groups.
Patients and methods: We identified all patients (N=773) with MM diagnosed in Malmö, Sweden, from January 1, 1950, through December 31, 2005. Using census data for the population of Malmö, we calculated age- and sex-specific incidence rates. Incidence rates were also calculated for 10-year birth cohorts. Analyses for trends were performed using the Poisson regression.
Results: From 1950 through 2005, the average annual age-adjusted (European standard population) incidence rate remained stable (Poisson regression, P=.07 for men and P=.67 for women). Also, comparisons between 10-year birth cohorts (from 1870-1879 to 1970-1979) failed to detect any increase. Between 1950-1959 and 2000-2005, the median age at diagnosis of MM increased from 70 to 74 years, and the proportion of newly diagnosed patients aged 80 years or older increased from 16% to 31%.
Conclusion: Our finding of stable MM incidence rates for all age groups during the past 5 decades suggests that recent clinical observations of an increase of MM in the young may reflect an increased referral stream of younger patients with MM, which in turn might be a consequence of improved access to better MM therapies. Importantly, because of the aging population, the proportion of patients with MM aged 80 years or older doubled between 1950-1959 and 2000-2005.
Figures
Similar articles
-
Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.Health Bull (Edinb). 1996 May;54(3):232-40. Health Bull (Edinb). 1996. PMID: 8707567
-
Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trends.BMJ Open. 2016 Jan 21;6(1):e009584. doi: 10.1136/bmjopen-2015-009584. BMJ Open. 2016. PMID: 26801465 Free PMC article.
-
Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979.N Engl J Med. 1984 Feb 16;310(7):421-4. doi: 10.1056/NEJM198402163100703. N Engl J Med. 1984. PMID: 6694682
-
Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).J Insur Med. 2018;47(4):203-211. doi: 10.17849/insm-47-04-1-9.1. Epub 2019 Jan 22. J Insur Med. 2018. PMID: 30668210
-
Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992.Arch Dermatol. 1997 Jun;133(6):735-40. Arch Dermatol. 1997. PMID: 9197827 Review.
Cited by
-
A Case of Multiple Myeloma Associated with Extramedullary Plasmacytoma of the Gallbladder Manifesting as Acute Cholecystitis.Cureus. 2018 May 25;10(5):e2688. doi: 10.7759/cureus.2688. Cureus. 2018. PMID: 30050743 Free PMC article.
-
Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?J Oncol. 2019 Apr 10;2019:2186494. doi: 10.1155/2019/2186494. eCollection 2019. J Oncol. 2019. PMID: 31093282 Free PMC article. Review.
-
Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.Clin Exp Immunol. 2016 Aug;185(2):239-51. doi: 10.1111/cei.12785. Clin Exp Immunol. 2016. PMID: 26940026 Free PMC article.
-
Aging: Treating the Older Patient.Biol Blood Marrow Transplant. 2017 Feb;23(2):193-200. doi: 10.1016/j.bbmt.2016.11.007. Epub 2016 Nov 15. Biol Blood Marrow Transplant. 2017. PMID: 27864162 Free PMC article. Review. No abstract available.
-
The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.Cancer Med. 2017 Jul;6(7):1807-1816. doi: 10.1002/cam4.1128. Epub 2017 Jun 22. Cancer Med. 2017. PMID: 28639741 Free PMC article.
References
-
- Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer Statistics 2000. CA Cancer J Clin. 2000;50:7-33_ - PubMed
-
- Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ., III Incidence of multiple myeloma in Olmsted County, Minnesota: trend over 6 decades. Cancer 2004;101:2667-2674 - PubMed
-
- Landgren O, Weiss BM. Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis. Leukemia 2009;23(10):1691-1697 Epub 2009 Jul 9 - PubMed
-
- Lewis DR, Pottern LM, Brown LM, et al. Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control. 1994;5:529-539 - PubMed
-
- Blattner WA, Blair A, Mason TJ. Multiple myeloma in the United States, 1950-1975. Cancer 1981;48:2547-2554 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous